Wilms' tumor Recruiting Phase 2 Trials for DB08875 (Cabozantinib)

Also known as: Wilms Tumour / Wilms Tumor / Wilm's Tumor / Wilm's tumour / Nephroma / Nephroblastoma

IndicationStatusPhase
DBCOND0021654 (Wilms' tumor)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02867592Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare TumorsTreatment